Investigational Drug Information for Sumanirole
✉ Email this page to a colleague
What is the development status for investigational drug Sumanirole?
Sumanirole is an investigational drug.
There have been 3 clinical trials for Sumanirole.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2001.
The most common disease conditions in clinical trials are Parkinson Disease and [disabled in preview]. The leading clinical trial sponsors are Pfizer and [disabled in preview].
Summary for Sumanirole
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 507 |
| WIPO Patent Applications | 189 |
| Japanese Patent Applications | 21 |
| Clinical Trial Progress | Phase 3 (2001-12-01) |
| Vendors | 0 |
Recent Clinical Trials for Sumanirole
| Title | Sponsor | Phase |
|---|---|---|
| Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease | Pfizer | Phase 3 |
| Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease. | Pfizer | Phase 3 |
| Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's Disease | Pfizer | Phase 3 |
Clinical Trial Summary for Sumanirole
Top disease conditions for Sumanirole
Top clinical trial sponsors for Sumanirole
US Patents for Sumanirole
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
